Latest Articles
Case Report: Two Instances of Lung Metastasis in Low-grade Endometrial Stromal Sarcoma - Frontiers
Case Report: Two Instances of Lung Metastasis in Low-grade Endometrial Stromal Sarcoma Frontiers
Published: June 30, 2025, 1:48 p.m.
Molecular Subtypes and Surgical Approaches in Endometrial Cancer - Physician's Weekly
Molecular Subtypes and Surgical Approaches in Endometrial Cancer Physician's Weekly
Published: June 28, 2025, 11:02 p.m.
The Immune Microenvironment in Endometrial Carcinoma: Mechanisms and - Frontiers
The Immune Microenvironment in Endometrial Carcinoma: Mechanisms and Frontiers
Published: June 27, 2025, 10:51 p.m.
Selinexor Maintenance Offers Durable Benefit in Advanced Endometrial Cancer - Oncology Nursing News
Selinexor Maintenance Offers Durable Benefit in Advanced Endometrial Cancer Oncology Nursing News
Published: June 27, 2025, 6:10 p.m.
AstraZeneca’s New Study on Endometrial Cancer: What Investors Need to Know - TipRanks
AstraZeneca’s New Study on Endometrial Cancer: What Investors Need to Know TipRanks
Published: June 27, 2025, 4:13 p.m.
RHOBH Star & Endometrial Cancer Survivor Praises 'Fur Babies' - SurvivorNet
RHOBH Star & Endometrial Cancer Survivor Praises 'Fur Babies' SurvivorNet
Published: June 26, 2025, 3:27 p.m.
LIN28B Promotes the Progression of Endometrial Cancer through Upregulating MYC and Correlates with Immune Microenvironment - Frontiers
LIN28B Promotes the Progression of Endometrial Cancer through Upregulating MYC and Correlates with Immune Microenvironment Frontiers
Published: June 26, 2025, 1:55 p.m.
Selinexor Maintenance Displays Durable Benefit in TP53 Wild-Type Advanced/Recurrent Endometrial Cancer - OncLive
Selinexor Maintenance Displays Durable Benefit in TP53 Wild-Type Advanced/Recurrent Endometrial Cancer OncLive
Published: June 25, 2025, 9:58 p.m.
New Ultrasound-Driven Model Boosts Accuracy in Diagnosing Endometrial Malignancy: Study Shows - Medical Dialogues
New Ultrasound-Driven Model Boosts Accuracy in Diagnosing Endometrial Malignancy: Study Shows Medical Dialogues
Published: June 25, 2025, 4:15 p.m.
Gilead Sciences’ Promising Phase 3 Study in Endometrial Cancer: A Potential Game-Changer? - TipRanks
Gilead Sciences’ Promising Phase 3 Study in Endometrial Cancer: A Potential Game-Changer? TipRanks
Published: June 25, 2025, 4:10 p.m.
Link copied to clipboard!